Human Immunodeficiency Virus Type 1: Resistance to Nucleoside Analogues and Replicative Capacity in Primary Human Macrophages

Documenti analoghi

• Effect of Cell Cycle Arrest on the Activity of Nucleoside Analogues against Human Immunodeficiency Virus Type 1
  di: Wurtzer, Sebastien, et al.
  Pubblicazione: (2005)
• Quantification of the Effects on Viral DNA Synthesis of Reverse Transcriptase Mutations Conferring Human Immunodeficiency Virus Type 1 Resistance to Nucleoside Analogues
  di: Bouchonnet, Francine, et al.
  Pubblicazione: (2005)
• Selective-Advantage Profile of Human Immunodeficiency Virus Type 1 Integrase Mutants Explains In Vivo Evolution of Raltegravir Resistance Genotypes
  di: Quercia, Romina, et al.
  Pubblicazione: (2009)
• Establishment of New Transmissible and Drug-Sensitive Human Immunodeficiency Virus Type 1 Wild Types due to Transmission of Nucleoside Analogue-Resistant Virus
  di: de Ronde, Anthony, et al.
  Pubblicazione: (2001)
• Infectivity and Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 1 Variants Isolated during Primary Infection
  di: Simon, Viviana, et al.
  Pubblicazione: (2003)